Global Digital Therapeutics Market -Industry Analysis and Forecast (2020-2027) by Sales Channel, by Application, and by Geography.

Global Digital Therapeutics Market -Industry Analysis and Forecast (2020-2027) by Sales Channel, by Application, and by Geography.

Market Scenario

Global Digital Therapeutics Market was valued at USD 2833.25 Mn in 2019 and is expected to reach at USD 11,555.44 Mn by 2027 at a CAGR of 19.21% over forecast period 2020-2027. Global Digital Therapeutics Market Dynamics: Digital therapeutics have the potential to address unmet patient needs that traditional treatments and therapies have been unable to cover. Digital Therapeutics stands for health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects and can be used to treat type II diabetes, Alzheimer’s disease, dementia, congestive heart failure, chronic obstructive pulmonary disease, and asthma. Factors such as growing need to control healthcare costs, upsurge in the incidence of chronic diseases, increasing focus on preventive healthcare and increase in venture capital investment are driving the market over forecast period. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. However, lack of awareness toward digital therapeutics acts as a key restraint to the market growth. On the contrary, high growth potential in the developing economies such as India, China, Brazil and Japan is expected to create lucrative opportunities for market. Global Digital Therapeutics Market Segmentation Analysis: Global Digital Therapeutics Market is segmented by sales channel, application, and geography. By sales channel B2B segment is expected to lead the market growth. This growth is attributed to the rising adoption of digital therapeutics in this segment, especially among payers and employers. By application, Preventive application segment held highest market share in 2019 and is expected to keep its dominance over forecast period thanks to government initiatives to increase the focus on preventive healthcare and a rising consensus among policymakers. Global Digital Therapeutics Market Regional Analysis: Geographically, North America held highest market share in 2019 and is expected to keep its dominance over forecast period. Factors such as increasing prevalence of chronic diseases and government initiatives to support technological advancement in digital therapeutics are boosting the market growth. The U.S. contributed largest revenue to the North American as well as global digital therapeutics market. The improving reimbursement structure for digital therapeutic solutions, and increasing investment in digital therapeutics field are the key growth driving factor for the U.S. digital therapeutics market. North America is followed by APAC. Continuous reforms in countries such as India and China to address a lack of proper infrastructure and maintain sustainable growth through financial inclusion will fuel the Digital Therapeutics Market in this region. Global Digital Therapeutics Market Competitive Landscape Report covers recent development and company profiles of major players. Some of the key players in the digital therapeutics market are Proteus Digital Health, Inc., Omada Health Inc., WellDoc, Inc., 2Morrow, Inc., Livongo Health. By using various inorganic and organic growth strategies such as merger and acquisition, expansion, patent, new product launches, and Joint ventures these players are increasing their regional presence and business operations. Recent Development • Propeller Health and Express Scripts entered into a partnership to provide Propeller’s FDA-cleared digital solutions to Express Scripts to manage asthma or COPD. • Canary Health entered into a partnership with NMRHCA to offer the Better Choices, Better Health (BCBH) digital therapeutics program in New Mexico. The objective of the report is to present a comprehensive analysis of Global Digital Therapeutics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Digital Therapeutics Market dynamics, structure by analyzing the market segments and project the Global Digital Therapeutics Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Digital Therapeutics Market make the report investor’s guide.

Global Digital Therapeutics Market, By Sales Channel

• B2B o Caregivers o Patients • B2C o Providers o Payers o Pharmaceutical Companies o Employers o Other Buyers

Global Digital Therapeutics Market, By Application

• Preventive Applications o Prediabetes o Obesity • Treatment/Care-Related Applications o Diabetes o Central Nervous System (CNS) Disorders o Chronic Respiratory Diseases (CRD) o Musculoskeletal Disorders o Cardiovascular Diseases o Smoking Cessation o Medication Adherence o Other Applications

Global Digital Therapeutics Market, By Geography:

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America

Key Players in the Global Digital Therapeutics Market Are:

• Evolent Health, Inc. • Pear Therapeutics, Inc. • WellDoc Inc. • Nanobiosym, Inc. • Twine Health, Inc. • Mango Health Inc. • Canary Health Inc. • 2morrow Inc. • Propeller Health • Ginger.Io, Inc. • Noom Inc. • Livongo Health • Welldoc, Inc. • Omada Health, Inc. • Proteus Digital Health, Inc. Available Customization Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.

Table of Contents

Global Digital Therapeutics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Digital Therapeutics Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Global Digital Therapeutics Market Analysis and Forecast 5.1. Global Digital Therapeutics Market Analysis and Forecast 5.2. Global Digital Therapeutics Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Digital Therapeutics Market Analysis and Forecast, by Sales Channel 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Digital Therapeutics Market Value Share Analysis, by Sales Channel 6.4. Market Size (US$ Mn) Forecast, by Sales Channel 6.5. Global Digital Therapeutics Market Analysis, by Sales Channel 6.6. Digital Therapeutics Market Attractiveness Analysis, by Sales Channel 7. Global Digital Therapeutics Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Global Digital Therapeutics Market Value Share Analysis, by Application 7.3. Market Size (US$ Mn) Forecast, by Application 7.4. Global Digital Therapeutics Market Analysis, by Application 7.5. Global Digital Therapeutics Market Attractiveness Analysis, by Application 8. Global Digital Therapeutics Market Analysis, by Region 8.1. Global Digital Therapeutics Market Value Share Analysis, by Region 8.2. Market Size (US$ Mn) Forecast, by Region 8.3. Global Digital Therapeutics Market Attractiveness Analysis, by Region 9. North America Digital Therapeutics Market Analysis 9.1. Key Findings 9.2. North America Digital Therapeutics Market Overview 9.3. North America Digital Therapeutics Market Value Share Analysis, by Sales Channel 9.4. North America Digital Therapeutics Market Forecast, by Sales Channel 9.4.1. B2B 9.4.2. B2C 9.5. North America Digital Therapeutics Market Value Share Analysis, by Application 9.6. North America Digital Therapeutics Market Forecast, by Application 9.6.1. Preventive Applications 9.6.2. Treatment/Care-Related Applications 9.7. North America Digital Therapeutics Market Value Share Analysis, by Country 9.8. North America Digital Therapeutics Market Forecast, by Country 9.8.1. U.S. 9.8.2. Canada 9.9. North America Digital Therapeutics Market Analysis, by Country 9.10. U.S. Digital Therapeutics Market Forecast, by Sales Channel 9.10.1. B2B 9.10.2. B2C 9.11. U.S. Digital Therapeutics Market Forecast, by Application 9.11.1. Preventive Applications 9.11.2. Treatment/Care-Related Applications 9.12. Canada Digital Therapeutics Market Forecast, by Sales Channel 9.12.1. B2B 9.12.2. B2C 9.13. Canada Digital Therapeutics Market Forecast, by Application 9.13.1. Preventive Applications 9.13.2. Treatment/Care-Related Applications 9.14. North America Digital Therapeutics Market Attractiveness Analysis 9.14.1. By Sales Channel 9.14.2. By Application 9.15. PEST Analysis 10. Europe Digital Therapeutics Market Analysis 10.1. Key Findings 10.2. Europe Digital Therapeutics Market Overview 10.3. Europe Digital Therapeutics Market Value Share Analysis, by Sales Channel 10.4. Europe Digital Therapeutics Market Forecast, by Sales Channel 10.4.1. B2B 10.4.2. B2C 10.5. Europe Digital Therapeutics Market Value Share Analysis, by Application 10.6. Europe Digital Therapeutics Market Forecast, by Application 10.6.1. Preventive Applications 10.6.2. Treatment/Care-Related Applications 10.7. Europe Digital Therapeutics Market Value Share Analysis, by Country 10.8. Europe Digital Therapeutics Market Forecast, by Country 10.8.1.1. Germany 10.8.1.2. U.K. 10.8.1.3. France 10.8.1.4. Italy 10.8.1.5. Spain 10.8.1.6. Rest of Europe 10.9. Europe Digital Therapeutics Market Analysis, by Country/ Sub-region 10.10. Germany Digital Therapeutics Market Forecast, by Sales Channel 10.10.1. B2B 10.10.2. B2C 10.11. Germany Digital Therapeutics Market Forecast, by Application 10.11.1. Preventive Applications 10.11.2. Treatment/Care-Related Applications 10.12. U.K. Digital Therapeutics Market Forecast, by Sales Channel 10.12.1. B2B 10.12.2. B2C 10.13. U.K. Digital Therapeutics Market Forecast, by Application 10.13.1. Preventive Applications 10.13.2. Treatment/Care-Related Applications 10.14. France Digital Therapeutics Market Forecast, by Sales Channel 10.14.1. B2B 10.14.2. B2C 10.15. France Digital Therapeutics Market Forecast, by Application 10.15.1. Preventive Applications 10.15.2. Treatment/Care-Related Applications 10.16. Italy Digital Therapeutics Market Forecast, by Sales Channel 10.16.1. B2B 10.16.2. B2C 10.17. Italy Digital Therapeutics Market Forecast, by Application 10.17.1. Preventive Applications 10.17.2. Treatment/Care-Related Applications 10.18. Spain Digital Therapeutics Market Forecast, by Sales Channel 10.18.1. B2B 10.18.2. B2C 10.19. Spain Digital Therapeutics Market Forecast, by Application 10.19.1. Preventive Applications 10.19.2. Treatment/Care-Related Applications 10.20. Rest of Europe Digital Therapeutics Market Forecast, by Sales Channel 10.20.1. B2B 10.20.2. B2C 10.21. Rest of Europe Digital Therapeutics Market Forecast, by Application 10.21.1. Preventive Applications 10.21.2. Treatment/Care-Related Applications 10.22. Europe Digital Therapeutics Market Attractiveness Analysis 10.22.1. By Sales Channel 10.22.2. By Application 10.23. PEST Analysis 11. Asia Pacific Digital Therapeutics Market Analysis 11.1. Key Findings 11.2. Asia Pacific Digital Therapeutics Market Overview 11.3. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Sales Channel 11.4. Asia Pacific Digital Therapeutics Market Forecast, by Sales Channel 11.4.1. B2B 11.4.2. B2C 11.5. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Application 11.6. Asia Pacific Digital Therapeutics Market Forecast, by Application 11.6.1. Preventive Applications 11.6.2. Treatment/Care-Related Applications 11.7. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Country 11.8. Asia Pacific Digital Therapeutics Market Forecast, by Country 11.8.1. China 11.8.2. India 11.8.3. Japan 11.8.4. ASEAN 11.8.5. Rest of Asia Pacific 11.9. Asia Pacific Digital Therapeutics Market Analysis, by Country/ Sub-region 11.10. China Digital Therapeutics Market Forecast, by Sales Channel 11.10.1. B2B 11.10.2. B2C 11.11. China Digital Therapeutics Market Forecast, by Application 11.11.1. Preventive Applications 11.11.2. Treatment/Care-Related Applications 11.12. India Digital Therapeutics Market Forecast, by Sales Channel 11.12.1. B2B 11.12.2. B2C 11.13. India Digital Therapeutics Market Forecast, by Application 11.13.1. Preventive Applications 11.13.2. Treatment/Care-Related Applications 11.14. Japan Digital Therapeutics Market Forecast, by Sales Channel 11.14.1. B2B 11.14.2. B2C 11.15. Japan Digital Therapeutics Market Forecast, by Application 11.15.1. Preventive Applications 11.15.2. Treatment/Care-Related Applications 11.16. ASEAN Digital Therapeutics Market Forecast, by Sales Channel 11.16.1. B2B 11.16.2. B2C 11.17. ASEAN Digital Therapeutics Market Forecast, by Application 11.17.1. Preventive Applications 11.17.2. Treatment/Care-Related Applications 11.18. Rest of Asia Pacific Digital Therapeutics Market Forecast, by Sales Channel 11.18.1. B2B 11.18.2. B2C 11.19. Rest of Asia Pacific Digital Therapeutics Market Forecast, by Application 11.19.1. Preventive Applications 11.19.2. Treatment/Care-Related Applications 11.20. Asia Pacific Digital Therapeutics Market Attractiveness Analysis 11.20.1. By Sales Channel 11.20.2. By Application 11.21. PEST Analysis 12. Middle East & Africa Digital Therapeutics Market Analysis 12.1. Key Findings 12.2. Middle East & Africa Digital Therapeutics Market Overview 12.3. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Sales Channel 12.4. Middle East & Africa Digital Therapeutics Market Forecast, by Sales Channel 12.4.1. B2B 12.4.2. B2C 12.5. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Application 12.6. Middle East & Africa Digital Therapeutics Market Forecast, by Application 12.6.1. Preventive Applications 12.6.2. Treatment/Care-Related Applications 12.7. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Country 12.8. Middle East & Africa Digital Therapeutics Market Forecast, by Country 12.8.1. GCC 12.8.2. South Africa 12.8.3. Rest of Middle East & Africa 12.9. Middle East & Africa Digital Therapeutics Market Analysis, by Country/ Sub-region 12.10. GCC Digital Therapeutics Market Forecast, by Sales Channel 12.10.1. B2B 12.10.2. B2C 12.11. GCC Digital Therapeutics Market Forecast, by Application 12.11.1. Preventive Applications 12.11.2. Treatment/Care-Related Applications 12.12. South Africa Digital Therapeutics Market Forecast, by Sales Channel 12.12.1. B2B 12.12.2. B2C 12.13. South Africa Digital Therapeutics Market Forecast, by Application 12.13.1. Preventive Applications 12.13.2. Treatment/Care-Related Applications 12.14. Rest of Middle East & Africa Digital Therapeutics Market Forecast, by Sales Channel 12.14.1. B2B 12.14.2. B2C 12.15. Rest of Middle East & Africa Digital Therapeutics Market Forecast, by Application 12.15.1. Preventive Applications 12.15.2. Treatment/Care-Related Applications 12.16. Middle East & Africa Digital Therapeutics Market Attractiveness Analysis 12.16.1. By Sales Channel 12.16.2. By Application 12.17. PEST Analysis 13. Latin America Digital Therapeutics Market Analysis 13.1. Key Findings 13.2. Latin America Digital Therapeutics Market Overview 13.3. Latin America Digital Therapeutics Market Value Share Analysis, by Sales Channel 13.4. Latin America Digital Therapeutics Market Forecast, by Sales Channel 13.4.1. B2B 13.4.2. B2C 13.5. Latin America Digital Therapeutics Market Value Share Analysis, by Application 13.6. Latin America Digital Therapeutics Market Forecast, by Application 13.6.1. Preventive Applications 13.6.2. Treatment/Care-Related Applications 13.7. Latin America Digital Therapeutics Market Value Share Analysis, by Country 13.8. Latin America Digital Therapeutics Market Forecast, by Country 13.8.1. Brazil 13.8.2. Mexico 13.8.3. Rest of Latin America 13.9. Latin America Digital Therapeutics Market Analysis, by Country/ Sub-region 13.10. Brazil Digital Therapeutics Market Forecast, by Sales Channel 13.10.1. B2B 13.10.2. B2C 13.11. Brazil Digital Therapeutics Market Forecast, by Application 13.11.1. Preventive Applications 13.11.2. Treatment/Care-Related Applications 13.12. Mexico Digital Therapeutics Market Forecast, by Sales Channel 13.12.1. B2B 13.12.2. B2C 13.13. Mexico Digital Therapeutics Market Forecast, by Application 13.13.1. Preventive Applications 13.13.2. Treatment/Care-Related Applications 13.14. Rest of Latin America Digital Therapeutics Market Forecast, by Sales Channel 13.14.1. B2B 13.14.2. B2C 13.15. Rest of Latin America Digital Therapeutics Market Forecast, by Application 13.15.1. Preventive Applications 13.15.2. Treatment/Care-Related Applications 13.16. Latin America Digital Therapeutics Market Attractiveness Analysis 13.16.1. By Sales Channel 13.16.2. By Application 13.17. PEST Analysis 14. Company Profiles 14.1. Market Share Analysis, by Company 14.2. Competition Matrix 14.3. Company Profiles: Key Players 14.3.1. Evolent Health, Inc. 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Business Strategy 14.3.1.4. Recent Developments 14.3.1.5. Manufacturing Footprint 14.3.2. Pear Therapeutics, Inc. 14.3.3. WellDoc Inc. 14.3.4. Nanobiosym, Inc. 14.3.5. Twine Health, Inc. 14.3.6. Mango Health Inc. 14.3.7. Canary Health Inc. 14.3.8. 2morrow Inc. 14.3.9. Propeller Health 14.3.10. Ginger.Io, Inc. 14.3.11. Noom Inc. 14.3.12. Livongo Health 14.3.13. Welldoc, Inc. 14.3.14. Omada Health, Inc. 14.3.15. Proteus Digital Health, Inc. 15. Primary Key Insights

About This Report

Report ID7003
Category Healthcare
Published DateJan 2020
No of Pages176
Contact Us